These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11605071)

  • 1. Modulation of soluble CD44 concentrations by hormone and anti-hormone treatment in gynecological tumor cell lines.
    Stickeler E; Therasakvichya S; Moebus VJ; Kieback DG; Runnebaum IB; Kreienberg R
    Oncol Rep; 2001; 8(6):1381-6. PubMed ID: 11605071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
    Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
    Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
    Dehmel A; Becker M; Lemm M; Fichtner I
    Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
    Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K
    Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts.
    Gong Y; Murphy LC; Murphy LJ
    J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):13-9. PubMed ID: 8049128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct effects of GnRH agonists in human hormone-sensitive endometrial cells.
    Sica G; Schinzari G; Angelucci C; Lama G; Iacopino F
    Mol Cell Endocrinol; 2001 May; 176(1-2):121-8. PubMed ID: 11369451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of parathyroid hormone-related protein messenger RNA expression by medroxyprogesterone acetate in breast cancer tissues.
    Sugimoto T; Shiba E; Watanabe T; Takai S
    Breast Cancer Res Treat; 1999 Jul; 56(1):11-23. PubMed ID: 10517339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y; Ballejo G; Murphy LC; Murphy LJ
    Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
    Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines.
    Vendrell JA; Bieche I; Desmetz C; Badia E; Tozlu S; Nguyen C; Nicolas JC; Lidereau R; Cohen PA
    Endocr Relat Cancer; 2005 Mar; 12(1):75-92. PubMed ID: 15788640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
    Zhao LJ; Wei LH; Li XP; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen exerts agonistic effects on clusterin and complement C3 gene expression in RUCA-I primary xenografts and metastases but not normal uterus.
    Zierau O; O'Sullivan J; Morrissey C; McDonald D; Wünsche W; Schneider MR; Tenniswood MP; Vollmer G
    Endocr Relat Cancer; 2004 Dec; 11(4):823-30. PubMed ID: 15613455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines.
    Ory K; Lebeau J; Levalois C; Bishay K; Fouchet P; Allemand I; Therwath A; Chevillard S
    Breast Cancer Res Treat; 2001 Aug; 68(3):187-98. PubMed ID: 11727956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural interferon-alpha activity in hormone-sensitive, hormone-resistant and autonomous human breast-cancer cell lines.
    Iacopino F; Robustelli della Cuna G; Sica G
    Int J Cancer; 1997 Jun; 71(6):1103-8. PubMed ID: 9185717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
    Mirkin S; Archer DF
    Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.
    Horii Y; Takei H; Koibuchi Y; Horiguchi J; Maemura M; Iino Y; Morishita Y
    Oncol Rep; 2006 May; 15(5):1191-5. PubMed ID: 16596185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of phospholipid turnover by steroid hormones in endometrial carcinoma and breast cancer cells.
    Krasil'nikov MA; Shatskaya VA; Kuzmina ZV; Barinov VV; Letyagin VP; Bassalyk LS
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):543-8. PubMed ID: 8393260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cytotoxicity of 4'-OH-tamoxifen and estradiol in human endometrial adenocarcinoma cells HEC-1A and HEC-1B.
    Cuevas ME; Lindeman TE
    Oncol Rep; 2015 Jan; 33(1):464-70. PubMed ID: 25351552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.